These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33328177)

  • 21. Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs.
    Cao Y; Li D; Fu Y; Bai Q; Chen Y; Bai X; Jing Z; Sun P; Bao H; Li P; Zhang J; Ma X; Lu Z; Liu Z
    Antiviral Res; 2017 Apr; 140():133-141. PubMed ID: 28161579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a multiplex Luminex assay for detecting swine antibodies to structural and nonstructural proteins of foot-and-mouth disease virus in Taiwan.
    Chen TH; Lee F; Lin YL; Pan CH; Shih CN; Tseng CH; Tsai HJ
    J Microbiol Immunol Infect; 2016 Apr; 49(2):196-207. PubMed ID: 25074628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Validation of Serotype-Specific Blocking ELISA for the Detection of Anti-FMDV O/A/Asia1/SAT2 Antibodies.
    Kashem MA; Sroga P; Salazar V; Amjad H; Hole K; Koziuk J; Yang M; Nfon C; Babiuk S
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage.
    Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    Antiviral Res; 2020 Oct; 182():104920. PubMed ID: 32828822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of foot-and-mouth disease-infected pigs from vaccinated pigs using antibody-detecting sandwich ELISA.
    Chen TH; Lee F; Lin YL; Dekker A; Chung WB; Pan CH; Jong MH; Huang CC; Lee MC; Tsai HJ
    J Vet Med Sci; 2011 Aug; 73(8):977-84. PubMed ID: 21467761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a solid-phase competition ELISA based on virus-like particles of foot-and-mouth disease virus serotype A for antibody detection.
    Zhang Y; Yan H; Yao Y; Zhang S; Xiao Y; Xu X; Huang B; Tian K
    Arch Virol; 2020 Jul; 165(7):1641-1646. PubMed ID: 32350612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction, Expression and Evaluation of Recombinant VP2 Protein for serotype-independent Detection of FMDV Seropositive Animals in Egypt.
    Salem R; El-Kholy AA; Omar OA; Abu El-Naga MN; Ibrahim M; Osman G
    Sci Rep; 2019 Jul; 9(1):10135. PubMed ID: 31300744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a competitive ELISA method based on VLPs detecting the antibodies of serotype A FMDV.
    Zhang Y; Wang R; Bai M; Wang X; Dong H; Li J; Mu S; Miao H; Song J; Sun S; Guo H
    J Virol Methods; 2022 Feb; 300():114406. PubMed ID: 34915087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges for Serology-Based Characterization of Foot-and-Mouth Disease Outbreaks in Endemic Areas; Identification of Two Separate Lineages of Serotype O FMDV in Uganda in 2011.
    Namatovu A; Belsham GJ; Ayebazibwe C; Dhikusooka MT; Wekesa SN; Siegismund HR; Muwanika VB; Tjørnehøj K
    Transbound Emerg Dis; 2015 Oct; 62(5):522-34. PubMed ID: 24118785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine.
    Li P; Lu Z; Bai X; Li D; Sun P; Bao H; Fu Y; Cao Y; Chen Y; Xie B; Yin H; Liu Z
    Vet Res; 2014 May; 45(1):51. PubMed ID: 24885414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
    Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
    J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of sensitivity and specificity in three commercial foot-and-mouth disease virus non-structural protein ELISA kits with swine sera in Taiwan.
    Chen SP; Ellis TM; Lee MC; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR
    Vet Microbiol; 2007 Jan; 119(2-4):164-72. PubMed ID: 17112687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals.
    Lu Z; Cao Y; Guo J; Qi S; Li D; Zhang Q; Ma J; Chang H; Liu Z; Liu X; Xie Q
    Vet Microbiol; 2007 Nov; 125(1-2):157-69. PubMed ID: 17601688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of foot-and-mouth disease serotype O by ELISA using a monoclonal antibody.
    Chen HT; Peng YH; Zhang YG; Liu XT
    Hybridoma (Larchmt); 2012 Dec; 31(6):462-4. PubMed ID: 23244327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of the Ceditest® FMDV type O and FMDV-NS enzyme-linked immunosorbent assays for detection of antibodies against Foot-and-mouth disease virus in selected livestock and wildlife species in Uganda.
    Ayebazibwe C; Mwiine FN; Balinda SN; Tjørnehøj K; Alexandersen S
    J Vet Diagn Invest; 2012 Mar; 24(2):270-6. PubMed ID: 22379044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a foot-and-mouth disease virus SAT serotype-specific 3ABC assay to differentiate infected from vaccinated animals.
    Chitray M; Grazioli S; Willems T; Tshabalala T; De Vleeschauwer A; Esterhuysen JJ; Brocchi E; De Clercq K; Maree FF
    J Virol Methods; 2018 May; 255():44-51. PubMed ID: 29428400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
    Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K
    Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a competitive chemiluminescence immunoassay using a monoclonal antibody recognizing 3B of foot-and-mouth disease virus for the rapid detection of antibodies induced by FMDV infection.
    Liu W; Zhang G; Yang S; Li J; Gao Z; Ge S; Yang H; Shao J; Chang H
    Virol J; 2021 Sep; 18(1):193. PubMed ID: 34565393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.